Legal Representation
Attorney
David W. Staple
USPTO Deadlines
Next Deadline
2107 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2025-04-22)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
17 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Apr 22, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
Apr 22, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
Mar 4, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
Mar 4, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Feb 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
Feb 11, 2025 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
Feb 11, 2025 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
Feb 11, 2025 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
Feb 11, 2025 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
Feb 11, 2025 | GNEA | F | EXAMINERS AMENDMENT E-MAILED | Loading... |
Nov 26, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Nov 26, 2024 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Nov 26, 2024 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Nov 21, 2024 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Nov 5, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Nov 5, 2024 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
May 7, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations, namely, IVIG (Intravenous Immunoglobulin); immune globulin and hyperimmune globulin for pharmaceutical purposes; immune globulin and hyperimmune globulin preparations for the treatment of primary and secondary immunodeficiencies; immune globulin and hyperimmune globulin preparations for the prevention or treatment of infectious diseases; hyperimmune globulin preparation for the prevention or treatment of hepatitis B
First Use Anywhere:
Sep 26, 2019
First Use in Commerce:
Sep 26, 2019
Additional Information
Design Mark
The mark consists of white text over a blue background with the word "ADMA" above the word "BIOLOGICS" to the left of a white droplet shape with yellow shading.
Color Claim
The color(s) blue, yellow and white is/are claimed as a feature of the mark.
Classification
International Classes
005
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"BIOLOGICS"